Human Enhancement Market By Product and End User - Global Industry Analysis And Forecast To 2027
Published On : November 2018 Pages : 180 Category: Healthcare IT Report Code : HC111638
Human Enhancement Market By Product (Wearable Enhancement and In-Built Enhancement) and End User (Industrial, Defense and Medical) - Global Industry Analysis And Forecast To 2027
Industry Outlook
The human enhancement is also referred to as human augmentation, is "any endeavor to permanently or temporarily defeat the present confinements related to the human body through artificial or natural means. The enhancement is the utilization of the innovation that intends to choose or change human capacities and characteristics, regardless of whether the adjustment results in capacities and characteristics which lie past the current human range. The emerging technologies in this field are; neurotechnology, human genetic engineering, nanomedicine, 3d bioprinting and methods for the engineered negligible senescence. Therefore, the Human Enhancement Market is anticipated to expand and has tremendous scope during the forecast period. The global Human Enhancement Market anticipated to flourish in the future by growing at a significantly higher CAGR.
Drivers & Restrains
The factors driving the market are; development in the healthcare to make it more perfect, the feature & strength factor in the defense sector, rapid technological development in the sensors & other components utilized in this field, increasing activities of research & development taking place in this field and various other factors. The restraining factors of the market are; rise in the concerns related to social, legal & ethical aspects, more cost of these equipment’s, less number of skilled personals in this field, etc.
Regional Insights
The North American region is leading the global Human Enhancement Market owing to factor like; rise in the technical development of the products used in this field, increasing demand for good products for the application in medical sector, etc.
Human Enhancement Market, By Region
-
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and market share of the overall industry.
- Vuzix Corporation
- Google Inc.
- Braingate Company
- Samsung Electronics Co. Ltd.
- Ekso Bionics Holdings Inc.
- Raytheon Company
- B-Temia Inc.
- Magic Leap Inc.
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2017 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
o Human Enhancement Market, By Product, Estimates and Forecast, 2017-2027 ($Million)
o Wearable Enhancement
o In-Built Enhancement
o Human Enhancement Market, By End User, Estimates and Forecast, 2017-2027 ($Million)
o Industrial
o Defense
o Medical
o Human Enhancement Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Human Enhancement Market , By Country
o U.S. Human Enhancement Market
o Canada Human Enhancement Market
o Mexico Human Enhancement Market
o Europe
§ Europe Human Enhancement Market , By Country
o Germany Human Enhancement Market
o UK Human Enhancement Market
o France Human Enhancement Market
o Russia Human Enhancement Market
o Italy Human Enhancement Market
o Rest of Europe Human Enhancement Market
o Asia-Pacific
§ Asia-Pacific Human Enhancement Market , By Country
o China Human Enhancement Market
o Japan Human Enhancement Market
o South Korea Human Enhancement Market
o India Human Enhancement Market
o Southeast Asia Human Enhancement Market
o Rest of Asia-Pacific Human Enhancement Market
o South America
§ South America Human Enhancement Market , By Country
o Brazil Human Enhancement Market
o Argentina Human Enhancement Market
o Columbia Human Enhancement Market
o Rest of South America Human Enhancement Market
o Middle East and Africa
§ Middle East and Africa Human Enhancement Market , By Country
o Saudi Arabia Human Enhancement Market
o UAE Human Enhancement Market
o Egypt Human Enhancement Market
o Nigeria Human Enhancement Market
o South Africa Human Enhancement Market
o Rest of MEA Human Enhancement Market
Table of Contents:
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. SWOT Analysis
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Human Enhancement Market, By Product
5.1. Introduction
5.2. Global Human Enhancement Revenue and Market Share by Product (2017-2027)
5.2.1. Global Human Enhancement Revenue and Revenue Share by Product (2017-2027)
5.3. Wearable Enhancement
5.3.1. Global Wearable Enhancement Revenue and Growth Rate (2017-2027)
5.4. In-Built Enhancement
5.4.1. Global In-Built Enhancement Revenue and Growth Rate (2017-2027)
6. Human Enhancement Market, By End User
6.1. Introduction
6.2. Global Human Enhancement Revenue and Market Share by End User (2017-2027)
6.2.1. Global Human Enhancement Revenue and Revenue Share by End User (2017-2027)
6.3. Industrial
6.3.1. Global Industrial Revenue and Growth Rate (2017-2027)
6.4. Defense
6.4.1. Global Defense Revenue and Growth Rate (2017-2027)
6.5. Medical
6.5.1. Global Medical Revenue and Growth Rate (2017-2027)
7. Human Enhancement Market, By Region
7.1. Introduction
7.2. Global Human Enhancement Revenue and Market Share by Regions
7.2.1. Global Human Enhancement Revenue by Regions (2017-2027)
7.3. North America Human Enhancement by Countries
7.3.1. North America Human Enhancement Revenue and Growth Rate (2017-2027)
7.3.2. North America Human Enhancement Revenue (Million USD) by Countries (2017-2027)
7.3.3. United States
7.3.3.1. United States Human Enhancement Revenue (Millions USD) and Growth Rate (2017-2027)
7.3.4. Canada
7.3.4.1. Canada Human Enhancement Revenue (Millions USD) and Growth Rate (2017-2027)
7.3.5. Mexico
7.3.5.1. Mexico Human Enhancement Revenue (Millions USD) and Growth Rate (2017-2027)
7.4. Europe Human Enhancement by Countries
7.4.1. Europe Human Enhancement Revenue and Growth Rate (2017-2027)
7.4.2. Europe Human Enhancement Revenue (Million USD) by Countries (2017-2027)
7.4.3. Germany
7.4.3.1. Germany Human Enhancement Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.4. France
7.4.4.1. France Human Enhancement Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.5. UK
7.4.5.1. UK Human Enhancement Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.6. Russia
7.4.6.1. Russia Human Enhancement Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.7. Italy
7.4.7.1. Italy Human Enhancement Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.8. Rest of Europe
7.4.8.1. Rest of Europe Human Enhancement Revenue (Millions USD) and Growth Rate (2017-2027)
7.5. Asia-Pacific Human Enhancement by Countries
7.5.1. Asia-Pacific Human Enhancement Revenue and Growth Rate (2017-2027)
7.5.2. Asia-Pacific Human Enhancement Revenue (Million USD) by Countries (2017-2027)
7.5.3. China
7.5.3.1. China Human Enhancement Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.4. Japan
7.5.4.1. Japan Human Enhancement Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.5. Korea
7.5.5.1. Korea Human Enhancement Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.6. India
7.5.6.1. India Human Enhancement Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.7. Southeast Asia
7.5.7.1. Southeast Asia Human Enhancement Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.8. Rest of Asia-Pacific
7.5.8.1. Rest of Asia-Pacific Human Enhancement Revenue (Millions USD) and Growth Rate (2017-2027)
7.6. South America Human Enhancement by Countries
7.6.1. South America Human Enhancement Revenue and Growth Rate (2017-2027)
7.6.2. South America Human Enhancement Revenue (Million USD) by Countries (2017-2027)
7.6.3. Brazil
7.6.3.1. Brazil Human Enhancement Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.4. Argentina
7.6.4.1. Argentina Human Enhancement Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.5. Columbia
7.6.5.1. Columbia Human Enhancement Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.6. Rest of South America
7.6.6.1. Rest of South America Human Enhancement Revenue (Millions USD) and Growth Rate (2017-2027)
7.7. Middle East and Africa Human Enhancement by Countries
7.7.1. Middle East and Africa Human Enhancement Revenue and Growth Rate (2017-2027)
7.7.2. Middle East and Africa Human Enhancement Revenue (Million USD) by Countries (2017-2027)
7.7.3. Saudi Arabia
7.7.3.1. Saudi Arabia Human Enhancement Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.4. United Arab Emirates
7.7.4.1. United Arab Emirates Human Enhancement Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.5. Egypt
7.7.5.1. Egypt Human Enhancement Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.6. Nigeria
7.7.6.1. Nigeria Human Enhancement Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.7. South Africa
7.7.7.1. South Africa Human Enhancement Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.8. Turkey
7.7.8.1. Turkey Human Enhancement Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.9. Rest of Middle East and Africa
7.7.9.1. Rest of Middle East and Africa Human Enhancement Revenue (Millions USD) and Growth Rate (2017-2027)
8. Company Profiles
8.1. Vuzix Corporation
8.1.1. Business Overview
8.1.2. Service Portfolio
8.1.3. Strategic Developments
8.1.4. Revenue and Market Share
8.2. Google Inc.
8.2.1. Business Overview
8.2.2. Service Portfolio
8.2.3. Strategic Developments
8.2.4. Revenue and Market Share
8.3. Braingate Company
8.3.1. Business Overview
8.3.2. Service Portfolio
8.3.3. Strategic Developments
8.3.4. Revenue and Market Share
8.4. Samsung Electronics Co. Ltd.
8.4.1. Business Overview
8.4.2. Service Portfolio
8.4.3. Strategic Developments
8.4.4. Revenue and Market Share
8.5. Ekso Bionics Holdings Inc.
8.5.1. Business Overview
8.5.2. Service Portfolio
8.5.3. Strategic Developments
8.5.4. Revenue and Market Share
8.6. Raytheon Company
8.6.1. Business Overview
8.6.2. Service Portfolio
8.6.3. Strategic Developments
8.6.4. Revenue and Market Share
8.7. B-Temia Inc.
8.7.1. Business Overview
8.7.2. Service Portfolio
8.7.3. Strategic Developments
8.7.4. Revenue and Market Share
8.8. Magic Leap Inc.
8.8.1. Business Overview
8.8.2. Service Portfolio
8.8.3. Strategic Developments
8.8.4. Revenue and Market Share
9. Global Human Enhancement Market Competition, by Manufacturer
9.1. Global Human Enhancement Revenue and Market Share by Manufacturer (2017-2017)
9.2. Global Human Enhancement Price By Region (2017-2017)
9.3. Top 5 Human Enhancement Manufacturer Market Share
9.4. Market Competition Trend
10. Human Enhancement Market Forecast (2017-2027)
10.1. Global Human Enhancement Revenue (Millions USD) and Growth Rate (2017-2027)
10.2. Human Enhancement Market Forecast by Regions (2017-2027)
10.2.1. North America Human Enhancement Market Forecast (2017-2027)
10.2.1.1. United States Human Enhancement Market Forecast (2017-2027)
10.2.1.2. Canada Human Enhancement Market Forecast (2017-2027)
10.2.1.3. Mexico Human Enhancement Market Forecast (2017-2027)
10.2.2. Europe Human Enhancement Market Forecast (2017-2027)
10.2.2.1. Germany Human Enhancement Market Forecast (2017-2027)
10.2.2.2. France Human Enhancement Market Forecast (2017-2027)
10.2.2.3. UK Human Enhancement Market Forecast (2017-2027)
10.2.2.4. Russia Human Enhancement Market Forecast (2017-2027)
10.2.2.5. Italy Human Enhancement Market Forecast (2017-2027)
10.2.2.6. Rest of Europe Human Enhancement Market Forecast (2017-2027)
10.2.3. Asia-Pacific Human Enhancement Market Forecast (2017-2027)
10.2.3.1. China Human Enhancement Market Forecast (2017-2027)
10.2.3.2. Japan Human Enhancement Market Forecast (2017-2027)
10.2.3.3. Korea Human Enhancement Market Forecast (2017-2027)
10.2.3.4. India Human Enhancement Market Forecast (2017-2027)
10.2.3.5. Southeast Asia Human Enhancement Market Forecast (2017-2027)
10.2.3.6. Rest of Asia-Pacific Human Enhancement Market Forecast (2017-2027)
10.2.4. South America Human Enhancement Market Forecast (2017-2027)
10.2.4.1. Brazil Human Enhancement Market Forecast (2017-2027)
10.2.4.2. Argentina Human Enhancement Market Forecast (2017-2027)
10.2.4.3. Columbia Human Enhancement Market Forecast (2017-2027)
10.2.4.4. Rest of South America Human Enhancement Market Forecast (2017-2027)
10.2.5. Middle East and Africa Human Enhancement Market Forecast (2017-2027)
10.2.5.1. Saudi Arabia Human Enhancement Market Forecast (2017-2027)
10.2.5.2. United Arab Emirates Human Enhancement Market Forecast (2017-2027)
10.2.5.3. Egypt Human Enhancement Market Forecast (2017-2027)
10.2.5.4. Nigeria Human Enhancement Market Forecast (2017-2027)
10.2.5.5. South Africa Human Enhancement Market Forecast (2017-2027)
10.2.5.6. Turkey Human Enhancement Market Forecast (2017-2027)
10.2.5.7. Rest of Middle East and Africa Human Enhancement Market Forecast (2017-2027)
10.3. Human Enhancement Market Forecast by Product (2017-2027)
10.3.1. Human Enhancement Forecast by Product (2017-2027)
10.3.2. Human Enhancement Market Share Forecast by Product (2017-2027)
10.4. Human Enhancement Market Forecast by End User (2017-2027)
10.4.1. Human Enhancement Forecast by End User (2017-2027)
10.4.2. Human Enhancement Market Share Forecast by End User (2017-2027)
List of Tables
List of Tables and Figures:
Figure United States Human Enhancement Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Human Enhancement Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Human Enhancement Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Human Enhancement Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Human Enhancement Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Human Enhancement Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Human Enhancement Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Human Enhancement Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Human Enhancement Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Human Enhancement Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Human Enhancement Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Human Enhancement Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Human Enhancement Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Human Enhancement Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Human Enhancement Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Human Enhancement Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Human Enhancement Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Human Enhancement Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Human Enhancement Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Human Enhancement Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Human Enhancement Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Human Enhancement Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Human Enhancement Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Human Enhancement Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Human Enhancement Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Human Enhancement Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Human Enhancement Revenue and Revenue Share by Product (2017-2018)
Figure Global Wearable Enhancement Revenue and Growth Rate (2017-2018)
Figure Global In-Built Enhancement Revenue and Growth Rate (2017-2018)
Table Global Human Enhancement Revenue and Revenue Share by End User (2017-2018)
Figure Global Industrial Revenue and Growth Rate (2017-2018)
Figure Global Defense Revenue and Growth Rate (2017-2018)
Figure Global Medical Revenue and Growth Rate (2017-2018)
Table Global Human Enhancement Revenue by Regions (2017-2018)
Figure North America Human Enhancement Growth Rate (2017-2018)
Figure North America Human Enhancement Revenue and Growth Rate (2017-2018)
Figure North America Human Enhancement by Countries (2017-2018)
Figure North America Human Enhancement Revenue (Million USD) by Countries (2017-2018)
Figure United States Human Enhancement Growth Rate (2017-2018)
Figure United States Human Enhancement Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Human Enhancement Growth Rate (2017-2018)
Figure Canada Human Enhancement Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Human Enhancement Growth Rate (2017-2018)
Figure Mexico Human Enhancement Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Human Enhancement Growth Rate (2017-2018)
Figure Europe Human Enhancement Revenue and Growth Rate (2017-2018)
Figure Europe Human Enhancement by Countries (2017-2018)
Figure Europe Human Enhancement Revenue (Million USD) by Countries (2017-2018)
Figure Germany Human Enhancement Growth Rate (2017-2018)
Figure Germany Human Enhancement Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Human Enhancement Growth Rate (2017-2018)
Figure France Human Enhancement Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Human Enhancement Growth Rate (2017-2018)
Figure UK Human Enhancement Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Human Enhancement Growth Rate (2017-2018)
Figure Russia Human Enhancement Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Human Enhancement Growth Rate (2017-2018)
Figure Italy Human Enhancement Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Human Enhancement Growth Rate (2017-2018)
Figure Rest of Europe Human Enhancement Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Human Enhancement Growth Rate (2017-2018)
Figure Asia-Pacific Human Enhancement Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Human Enhancement by Countries (2017-2018)
Figure Asia-Pacific Human Enhancement Revenue (Million USD) by Countries (2017-2018)
Figure China Human Enhancement Growth Rate (2017-2018)
Figure China Human Enhancement Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Human Enhancement Growth Rate (2017-2018)
Figure Japan Human Enhancement Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Human Enhancement Growth Rate (2017-2018)
Figure Korea Human Enhancement Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Human Enhancement Growth Rate (2017-2018)
Figure India Human Enhancement Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Human Enhancement Growth Rate (2017-2018)
Figure Southeast Asia Human Enhancement Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Human Enhancement Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Human Enhancement Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Human Enhancement Growth Rate (2017-2018)
Figure South America Human Enhancement Revenue and Growth Rate (2017-2018)
Figure South America Human Enhancement by Countries (2017-2018)
Figure South America Human Enhancement Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Human Enhancement Growth Rate (2017-2018)
Figure Brazil Human Enhancement Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Human Enhancement Growth Rate (2017-2018)
Figure Argentina Human Enhancement Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Human Enhancement Growth Rate (2017-2018)
Figure Columbia Human Enhancement Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Human Enhancement Growth Rate (2017-2018)
Figure Rest of South America Human Enhancement Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Human Enhancement Growth Rate (2017-2018)
Figure Middle East and Africa Human Enhancement Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Human Enhancement by Countries (2017-2018)
Figure Middle East and Africa Human Enhancement Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Human Enhancement Growth Rate (2017-2018)
Figure Saudi Arabia Human Enhancement Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Human Enhancement Growth Rate (2017-2018)
Figure United Arab Emirates Human Enhancement Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Human Enhancement Growth Rate (2017-2018)
Figure Egypt Human Enhancement Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Human Enhancement Growth Rate (2017-2018)
Figure Nigeria Human Enhancement Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Human Enhancement Growth Rate (2017-2018)
Figure South Africa Human Enhancement Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Human Enhancement Growth Rate (2017-2018)
Figure Turkey Human Enhancement Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Human Enhancement Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Human Enhancement Revenue (Millions USD) and Growth Rate (2017-2018)
Table Vuzix Corporation Human Enhancement Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Google Inc. Human Enhancement Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Braingate Company Human Enhancement Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Samsung Electronics Co. Ltd. Human Enhancement Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Ekso Bionics Holdings Inc. Human Enhancement Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Raytheon Company Human Enhancement Price, Revenue, Gross Margin and Market Share (2017-2017)
Table B-Temia Inc. Human Enhancement Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Magic Leap Inc. Human Enhancement Price, Revenue, Gross Margin and Market Share (2017-2017)
Figure Global Human Enhancement Market Share by Manufacturer
Figure Global Human Enhancement Revenue and Market Share by Manufacturer
Table Global Human Enhancement Price by Region (2017-2017)
Figure Top 5 Human Enhancement Manufacturer (Revenue) Market Share
Figure Market Competition Trend
Figure Global Human Enhancement Revenue (Millions USD) and Growth Rate (2018-2025)
Table Human Enhancement Market Forecast by Regions (2018-2025)
Figure North America Human Enhancement Market Forecast (2018-2025)
Figure United States Human Enhancement Market Forecast (2018-2025)
Figure Canada Human Enhancement Market Forecast (2018-2025)
Figure Mexico Human Enhancement Market Forecast (2018-2025)
Figure Europe Human Enhancement Market Forecast (2018-2025)
Figure Germany Human Enhancement Market Forecast (2018-2025)
Figure France Human Enhancement Market Forecast (2018-2025)
Figure UK Human Enhancement Market Forecast (2018-2025)
Figure Russia Human Enhancement Market Forecast (2018-2025)
Figure Italy Human Enhancement Market Forecast (2018-2025)
Figure Rest of Europe Human Enhancement Market Forecast (2018-2025)
Figure Asia-Pacific Human Enhancement Market Forecast (2018-2025)
Figure China Human Enhancement Market Forecast (2018-2025)
Figure Japan Human Enhancement Market Forecast (2018-2025)
Figure Korea Human Enhancement Market Forecast (2018-2025)
Figure India Human Enhancement Market Forecast (2018-2025)
Figure Southeast Asia Human Enhancement Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Human Enhancement Market Forecast (2018-2025)
Figure South America Human Enhancement Market Forecast (2018-2025)
Figure Brazil Human Enhancement Market Forecast (2018-2025)
Figure Argentina Human Enhancement Market Forecast (2018-2025)
Figure Columbia Human Enhancement Market Forecast (2018-2025)
Figure Rest of South America Human Enhancement Market Forecast (2018-2025)
Figure Middle East and Africa Human Enhancement Market Forecast (2018-2025)
Figure Saudi Arabia Human Enhancement Market Forecast (2018-2025)
Figure United Arab Emirates Human Enhancement Market Forecast (2018-2025)
Figure Egypt Human Enhancement Market Forecast (2018-2025)
Figure Nigeria Human Enhancement Market Forecast (2018-2025)
Figure South Africa Human Enhancement Market Forecast (2018-2025)
Figure Turkey Human Enhancement Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Human Enhancement Market Forecast (2018-2025)
Figure Global Human Enhancement Forecast by Product (2018-2025)
Figure Global Human Enhancement Market Share Forecast by Product (2018-2025)
Figure Global Human Enhancement Forecast by Product (2018-2025)
Figure Global Human Enhancement Forecast by End User (2018-2025)
Figure Global Human Enhancement Market Share Forecast by End User (2018-2025)
Figure Global Human Enhancement Forecast by End User (2018-2025)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|